ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Hao Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0018-480X; OpenAlex author ID A5100353616. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactylation. Last author DOI 10.1186/s12885-025-15172-y ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lei Gao · 1 shared paper, 2025 · strength 0.26
- Paper Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactyla… DOI 10.1186/s12885-025-15172-y ↗
Xiaolong Liu · 1 shared paper, 2025 · strength 0.26
- Paper Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactyla… DOI 10.1186/s12885-025-15172-y ↗
Zhen Ma · 1 shared paper, 2025 · strength 0.26
- Paper Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactyla… DOI 10.1186/s12885-025-15172-y ↗
Bin Ma · 1 shared paper, 2025 · strength 0.26
- Paper Cyclin B2 facilitates glycolysis and tumor progression in pancreatic ductal adenocarcinoma by promoting histone lactyla… DOI 10.1186/s12885-025-15172-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.